Issued Patents All Time
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10251842 | Nanocapsule containing a bioactive compound, and a method of reducing toxicity resulting from cancer therapy | Amna Saddiq, Deena S. Mousa | 2019-04-09 |
| 9956181 | Composition of nanoformulated lycopene and method of using the composition | Mohammed H. Qari, Mohammed S. Ardawi | 2018-05-01 |
| 9707318 | Compositions of novel bone patch in bone and vascular regeneration | Mohammed H. Qari, Mohammed S. Ardawi | 2017-07-18 |
| 9700042 | Nanoformulation of musk-derived bioactive ingredients for nanocosmetic applications | Amna Saddiq | 2017-07-11 |
| 9572831 | Composition and method for sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasis | — | 2017-02-21 |
| 8563053 | Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis | Mohammed H. Qari, Mohammed S. Ardawi | 2013-10-22 |
| 8142992 | Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier | Lakshman R. Sehgal | 2012-03-27 |
| 8129104 | Platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with hemoglobin | Lakshman R. Sehgal | 2012-03-06 |
| 8129103 | Use of a platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier | Lakshman R. Sehgal | 2012-03-06 |
| 7964338 | Platelet preservation composition containing eptifibatide, a reversible factor IIa inhibitor and a hemoglobin oxygen carrier | Lakshman R. Sehgal | 2011-06-21 |
| 7332161 | Treatment of disease with antibodies against high molecular weight kininogen domain 5 | Robert W. Colman | 2008-02-19 |
| 6994852 | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 | Robert W. Colman | 2006-02-07 |
| 6346517 | Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders | Pancras C. Wong | 2002-02-12 |
| 6284726 | Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5 | Robert W. Colman | 2001-09-04 |